Opendata, web and dolomites

BIOREMIA SIGNED

BIOfilm-REsistant Materials for hard tissue Implant Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BIOREMIA project word cloud

Explore the words cloud of the BIOREMIA project. It provides you a very rough idea of what is the project "BIOREMIA" about.

entrepreneurship    forming    employers    society    training    regulation    mind    skills    experts    scientific    holistic    infections    hands    transferable    involvement    courses    communication    switzerland    strategies    biochemistry    ipr    supervised    materials    complemented    network    healthcare    usa    young    netherlands    phd    dental    implant    class    infection    nanotechnology    device    ireland    greece    recruit    consulting    beneficiaries    france    caused    medical    industrial    bacteria    sweden    spain    surfaces    education    productivity    doctoral    links    15    academic    minimizing    combining    career    citizens    esrs    careers    attractive    world    11    oriented    biofilm    inter    disciplinary    innovative    rates    austria    biomaterials    online    perspective    successful    patient    joint    microbiology    antibacterial    industry    biotechnology    countries    bioremia    doors    orthopaedic    italy    uk    innovation    engineering    students    surface    manufacturing    delivering    trained    technologies    germany    participating   

Project "BIOREMIA" data sheet

The following table provides information about the project.

Coordinator
LEIBNIZ-INSTITUT FUER FESTKOERPER- UND WERKSTOFFFORSCHUNG DRESDEN E.V. 

Organization address
address: HELMHOLTZSTRASSE 20
city: DRESDEN
postcode: 1069
website: www.ifw-dresden.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 4˙029˙973 €
 EC max contribution 4˙029˙973 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LEIBNIZ-INSTITUT FUER FESTKOERPER- UND WERKSTOFFFORSCHUNG DRESDEN E.V. DE (DRESDEN) coordinator 505˙576.00
2    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 606˙345.00
3    GOETEBORGS UNIVERSITET SE (GOETEBORG) participant 563˙965.00
4    UNIVERSIDAD AUTONOMA DE BARCELONA ES (CERDANYOLA DEL VALLES) participant 501˙809.00
5    PX SERVICES SA CH (LA CHAUX-DE-FONDS) participant 281˙276.00
6    ANTHOGYR SAS FR (SALLANCHES) participant 274˙802.00
7    ASHLAND SPECIALTIES IRELAND LIMITED IE (Dublin) participant 274˙684.00
8    MONTANUNIVERSITAET LEOBEN AT (LEOBEN) participant 264˙207.00
9    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 261˙499.00
10    STRYKER TRAUMA GMBH DE (SCHONKIRCHEN) participant 252˙788.00
11    PANEPISTIMIO IOANNINON EL (IOANNINA) participant 243˙017.00

Map

 Project objective

Implant-associated infections, commonly caused by biofilm-forming bacteria, are highly problematic for the patient, the healthcare system, and society. BIOREMIA will recruit 15 doctoral students (ESRs) and provide a highly inter-disciplinary joint research & training programme focused on the key issues that determine the future antibacterial biomaterials and technologies for orthopaedic and dental applications. BIOREMIA links 7 academic and 4 non-academic beneficiaries as well as 6 partners from 11 European countries (Germany, Austria, Greece, Sweden, UK, Spain, Italy, France, Switzerland, Ireland and the Netherlands) and the USA. The ESRs will be supervised and trained by world-class academic and industrial organisations, combining technical knowledge with hands-on training in state-of-the-art research projects. BIOREMIA training program will include face-to-face and online scientific courses in biomaterials & surface engineering, biotechnology,nanotechnology, implant manufacturing, biochemistry, microbiology and biofilm. This will be complemented by education in transferable skills such as entrepreneurship, management, IPR, communication etc. useful for getting an innovation-oriented mind-set of young researchers. Participating in BIOREMIA will make PhD students highly attractive for employers and open up doors for their successful careers in research, regulation, consulting, industry and the healthcare system. They will be experts for the better assessment of the antibacterial functionality of materials and surfaces and for delivering successful strategies for the medical device industry and the healthcare system. The strong involvement of the industrial sector will provide the ESRs with a holistic perspective on career opportunities. Beyond the trained researchers, this network will produce innovative materials and technologies that will enhance the productivity of European industry and improve the well-being of European citizens by minimizing implant-associated infection rates.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOREMIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOREMIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

MLFPM2018 (2019)

Machine Learning Frontiers in Precision Medicine

Read More